Prolonged low-dose intravenous thrombolysis in a stroke patient with distal basilar thrombus

Stroke

Volumn 37, Issue 1, 2006, Pages

  Veltkamp, Roland ^a   Jacobi, Christian ^a   Kress, Bodo ^a   Hacke, Werner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Ischemia; Magnetic resonance imaging; Reperfusion; Thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; BASILAR ARTERY; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; BRAIN STEM INFARCTION; CASE REPORT; HIGH RISK PATIENT; HUMAN; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PRIORITY JOURNAL; STROKE; THROMBOEMBOLISM; CEREBROVASCULAR ACCIDENT; EMBOLISM; FIBRINOLYTIC THERAPY; METHODOLOGY; PATHOLOGY; REPERFUSION; RISK; STENOSIS, OCCLUSION AND OBSTRUCTION; THROMBOSIS; TIME; VERTEBROBASILAR INSUFFICIENCY;

AGED; CEREBROVASCULAR ACCIDENT; CONSTRICTION, PATHOLOGIC; EMBOLISM; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; RECOMBINANT PROTEINS; REPERFUSION; RISK; THROMBOLYTIC THERAPY; THROMBOSIS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; VERTEBROBASILAR INSUFFICIENCY;

EID: 33644878703     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000195171.29940.79     Document Type: Article

References (9)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Schellinger PD, Kaste M, Hacke W. An update on thrombolytic therapy for acute stroke. Curr Opin Neurol. 2004;17:69-77.
3. Schellinger PD, Fiebach JB, Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke. 2003;34:575-583.
4. Wang M, Hays T, Balassa V, Bagatell R, Gruppo R, Grabowski EF, Valentino LA, Tsao-Wu G, Manco-Johnson MJ. Low-dose tissue plasminogen activator thrombolysis in children. J Ped Hematol Oncol. 2003;379-386.
5. Madhavan P, Sultan S, McDonnell CO, Cowman JP, Colgan MP, McEniff N, Molloy M, Moore DJ, Shanik G. Low dose intraarterial thrombolysis with tissue plasminogen activator: does it deliver as promised? Vasc Endovasc Surg. 2002;36:351-356.
6. Herron SB, Lax D, Zamora R. Successful thrombolysis of acute left atrial thrombi in two pediatric patients following interventional cardiac catheterization. J Invasive Cardiol. 2004;16:35-39.
7. Kulkarni S, Rodriguez M, Lafuente A, Mateos P, Mehta J, Singhal S, Saso R, Tait D, Treleaven JG, Powles RL. Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD). Bone Marrow Transplant. 1999;23:803-807.
8. Fassbender K, Dempfle CE, Mielke O, Schwartz A, Daffertshofer M, Eschenfelder C, Dolllmann M, Hennerici M. Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator. Stroke. 1999;30:2101-2104.
9. Stangl K, Laule M, Tenckhoff B, Stangl V, Gliech V, Dubel P, Grohmann A, Melzer C, Langel J, Wernecke KD, Baumann G, Ziemer S. Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during alteplase double-bolus regimen in acute myocardial infarction. Am J Cardiol. 1998;81:841-847.